1. Home
  2. CORT vs GDS Comparison

CORT vs GDS Comparison

Compare CORT & GDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • GDS
  • Stock Information
  • Founded
  • CORT 1998
  • GDS 2001
  • Country
  • CORT United States
  • GDS China
  • Employees
  • CORT N/A
  • GDS N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • GDS Computer Software: Programming Data Processing
  • Sector
  • CORT Health Care
  • GDS Technology
  • Exchange
  • CORT Nasdaq
  • GDS Nasdaq
  • Market Cap
  • CORT 7.5B
  • GDS 6.7B
  • IPO Year
  • CORT N/A
  • GDS 2016
  • Fundamental
  • Price
  • CORT $69.15
  • GDS $36.52
  • Analyst Decision
  • CORT Strong Buy
  • GDS Strong Buy
  • Analyst Count
  • CORT 4
  • GDS 6
  • Target Price
  • CORT $142.00
  • GDS $40.57
  • AVG Volume (30 Days)
  • CORT 856.9K
  • GDS 2.2M
  • Earning Date
  • CORT 08-05-2025
  • GDS 08-20-2025
  • Dividend Yield
  • CORT N/A
  • GDS N/A
  • EPS Growth
  • CORT 8.36
  • GDS N/A
  • EPS
  • CORT 1.14
  • GDS 3.31
  • Revenue
  • CORT $685,446,000.00
  • GDS $1,462,549,715.00
  • Revenue This Year
  • CORT $35.85
  • GDS $15.11
  • Revenue Next Year
  • CORT $35.22
  • GDS $13.47
  • P/E Ratio
  • CORT $60.53
  • GDS $11.95
  • Revenue Growth
  • CORT 30.93
  • GDS 8.23
  • 52 Week Low
  • CORT $32.33
  • GDS $9.88
  • 52 Week High
  • CORT $117.33
  • GDS $52.50
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.05
  • GDS 62.65
  • Support Level
  • CORT $67.44
  • GDS $35.84
  • Resistance Level
  • CORT $73.78
  • GDS $37.29
  • Average True Range (ATR)
  • CORT 2.08
  • GDS 1.32
  • MACD
  • CORT -0.31
  • GDS -0.12
  • Stochastic Oscillator
  • CORT 26.97
  • GDS 60.50

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About GDS GDS Holdings Limited ADS

GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.

Share on Social Networks: